IPO filing research

Dror Ortho-Design, Inc.

Dental Equipment & Supplies · DROR

follow-on amended Nasdaq Capital Market S-1/A

Dror Ortho-Design, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1/A on 2026-04-01. Current deal snapshot: exchange Nasdaq Capital Market.

Filing Timeline

SEC EDGAR

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Price $4.13 · 3,636,364 shares

Common Stock · Exchange Nasdaq Capital Market · Ticker DROR · Over-allotment 545,455 · Prefunded warrants to purchase common stock at $0.0001 per share and underwriter warrants exercisable at 125% of the offering price · Flags warrants · Underwriters Titan Partners Group

Dror Ortho-Design, Inc. is conducting an IPO offering up to 3,636,364 shares of common stock and related warrants, with an assumed public offering price of $4.13 per share. The filing includes a reverse stock split adjustment (1-for-550) and intends to list on Nasdaq Capital Market. The company remains in the development stage with no revenue, relying on proprietary AI technology for orthodontic solutions. The offering includes prefunded and underwriter warrants, with risks related to market acceptance, regulatory compliance, and competitive pressures.

2026-04-01 · 0001213900-26-037951

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

Price $4.95 · 2,020,203 shares

Common Stock · Exchange NYSE American · Ticker DROR · Over-allotment 303,030 · Prefunded warrants to purchase common stock at $0.0001 per share and underwriter warrants exercisable at 125% of the offering price · Use of proceeds Proceeds to the company for general corporate purposes · Underwriters Titan Partners Group

Dror Ortho-Design, Inc. is conducting an IPO offering up to 2,020,203 shares of common stock and related warrants, with a focus on its AI-based orthodontic platform. The company plans to list on the NYSE American following the offering, pending approval. A 1-for-450 reverse stock split is expected to take effect, adjusting outstanding shares and stock prices. The offering includes prefunded and underwriter warrants, with underwriters receiving compensation and warrants exercisable at 125% of the offering price.

2026-02-03 · 0001213900-26-010996

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1 filing.

Price $4.95 · 2,020,203 shares · Gross proceeds $10,000,000

Common Stock · Exchange NYSE American · Ticker DROR · Over-allotment 303,030 · Prefunded warrants to purchase up to 2,020,203 shares at $0.0001 exercise price; underwriter warrants to purchase 141,414 shares at 125% of offering price ($6.1875) · Use of proceeds General corporate purposes · Flags warrants · Underwriters underwriters

Dror Ortho-Design, Inc. is conducting an IPO with an assumed public offering price of $4.95 per share for up to 2,020,203 shares of common stock, along with prefunded and underwriter warrants. The company plans to effect a 1-for-450 reverse stock split prior to the offering, adjusting outstanding shares and warrants. The filing includes details about the offering structure, underwriters (Titan Partners Group), and risks related to its early-stage operations, regulatory compliance, and market competition. The company aims to list on the NYSE American, contingent on approval.

2025-07-14 · 0001213900-25-063798

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows DRS in the pre-IPO sequence.

Common Stock · Exchange NYSE American · Ticker DROR · Prefunded Warrants to purchase common stock at $0.0001 per share; Underwriter Warrants exercisable at 125% of offering price · Use of proceeds General corporate purposes · Underwriters Titan Partners Group

Dror Ortho-Design, Inc. is conducting an IPO to offer up to [●] shares of common stock, prefunded warrants, and underwriter warrants. The company plans to effect a 1-for-[●] reverse stock split and intends to list its common stock on the NYSE American. The offering includes terms for over-allotment options and underwriting discounts, with the final offering price determined through negotiation. The company has no operating history in manufacturing orthodontic devices and faces significant risks related to market acceptance, regulatory compliance, and competition.

2025-05-28 · 0001213900-25-048332

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

Begins the tracked draft filing sequence after EFFECT.

Dror Ortho-Design, Inc. has submitted a confidential draft registration statement (Form S-1) for a proposed public offering of up to shares of common stock, prefunded warrants, and underwriter warrants. The offering includes a 1-for-[●] reverse stock split, with adjusted share numbers and prices. The company aims to list on Nasdaq following the offering, though approval is not guaranteed. The filing highlights risks related to its unproven platform, regulatory hurdles, and lack of revenue. Titan Partners Group is the sole bookrunner.

2025-04-10 · 0001213900-25-030681

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

Price $0.01 · 2,304,316,461 shares · Gross proceeds $0.00

Common Stock · Exchange OTC Pink · Ticker DROR · Collectively, the Share Exchange Warrants and Private Placement Warrants · Selling stockholders only · Use of proceeds general corporate purposes · Flags warrants

Dror Ortho-Design, Inc. is registering the resale of 2,304,316,461 shares of common stock, including shares from a private placement, convertible preferred stock, and warrants, to satisfy registration rights agreements. The company, formerly Novint Technologies, Inc., rebranded after a share exchange with Private Dror, a subsidiary incorporated in Israel. The offering allows selling securityholders to resell shares at $0.011 per share until listed on a public market, with no underwriters involved.

2024-06-17 · 0001213900-24-053390

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows S-1/A and marks the registration effective.

Dror Ortho-Design, Inc. has received effectiveness for its S-1 registration statement, enabling the resale of 2.3 billion shares of common stock by selling securityholders. The filing relates to shares issued through a share exchange, private placement, and warrant exercises, with proceeds intended for general corporate purposes. The company, formerly Novint Technologies, Inc., rebranded after acquiring Dror Ortho-Design Ltd. and is currently quoted on the OTC Pink Market.

2024-06-14 · 9999999995-24-001851

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1/A filing.

2,304,316,461 shares

Common Stock of Dror Ortho-Design, Inc. · Exchange OTC Pink · Ticker DROR · Private Placement Warrants and Share Exchange Warrants exercisable for Common Stock · Selling stockholders only · Use of proceeds Use of proceeds from warrant exercises for general corporate purposes · Flags foreign_private_issuer, warrants · Underwriters self-underwritten

Dror Ortho-Design, Inc. is registering the resale of 2,304,316,461 shares of common stock, including shares from private placements, convertible preferred stock, and warrants, to satisfy registration rights agreements. The offering includes shares acquired through a share exchange and private placement transactions. The company, formerly Novint Technologies, Inc., rebranded after acquiring Private Dror's business. The prospectus outlines resale terms, pricing, and risks associated with the securities.

2024-06-05 · 0001213900-24-050050

S-1/A amended

Amended registration statement

Updated registration statement filed after SEC comments or deal changes.

Updates the prior S-1 filing.

2,304,316,461 shares

Common Stock · Exchange OTC Pink · Ticker DROR · Includes 474,999,993 Private Placement Warrant Shares and 489,834,426 Share Exchange Warrant Shares · Selling stockholders only · Use of proceeds General corporate purposes if warrants are exercised · Flags warrants, self_underwritten · Underwriters self-underwritten

Dror Ortho-Design, Inc. is conducting an IPO to register the resale of 2,304,316,461 shares of common stock, including shares from a private placement, share exchange, and warrants. The company, formerly Novint Technologies, Inc., rebranded after acquiring Private Dror through a share exchange. The offering includes shares issued to private placement investors and warrants exercisable for additional common stock. The registration satisfies a registration rights agreement, with proceeds from warrant exercises used for general corporate purposes.

2024-04-17 · 0001213900-24-033845

S-1 filed

Initial registration statement

Initial public filing submitted to start the SEC review process.

Follows RW in the pre-IPO sequence.

Dror Ortho-Design, Inc. filed an S-1 registration statement for an initial public offering (IPO), transitioning from a previous Registration Withdrawal Request (RW). The company, incorporated in Delaware, operates in Israel and focuses on orthopedic design. The filing includes financial data and corporate structure details but lacks extensive business operations or risk disclosures. Key entities include Dror Ortho-Design Ltd. and Novint Technologies, Inc.

2024-02-09 · 0001999371-24-001801

RW withdrawn

Withdrawal request

Issuer requested withdrawal of the registration statement.

Follows RW and ends the active registration process.

Novint Technologies, Inc. has submitted a registration withdrawal request for its Form 10-12G/A filing, stating the registration statement has not been declared effective by the SEC. The company previously withdrew a similar filing in November 2019 due to unresolved SEC comments, but the current filing does not mention ongoing issues or plans for a revised registration.

2020-01-23 · 0001387131-20-000418

RW withdrawn

Withdrawal request

Issuer requested withdrawal of the registration statement.

Follows EFFECT and ends the active registration process.

Novint Technologies, Inc. withdrew its registration statement on Form 10 due to unresolved SEC comments, intending to file a revised statement. The previous filing was a prospectus supplement with financial data through September 2007, while the current withdrawal request highlights ongoing regulatory challenges.

2020-01-07 · 0001387131-20-000114

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

Common

This is a prospectus supplement for Novint Technologies, Inc., updating the August 2007 prospectus with financial information for the quarterly period ended September 30, 2007. The filing includes updated balance sheets, statements of operations, changes in stockholders' equity, and cash flows, reflecting continued operating losses and financial challenges.

2007-11-16 · 0001144204-07-062511

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

Common · Exchange NASDAQ · Ticker NOVNT

The current filing updates the prospectus with financial information for the quarterly period ended September 30, 2007, superseding部分内容 of the previous prospectus. The filing includes unaudited financial statements, statements of operations, changes in stockholders' equity, and cash flows, reflecting updated financial performance and position compared to the prior period.

2007-11-16 · 0001144204-07-062508

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

20,136,113 shares

Common · Selling stockholders only · Use of proceeds Proceeds will be received by the selling stockholders.

The filing updates the prospectus with financial information for the quarter ended June 30, 2007, including balance sheet, income statement, and cash flow data. The company reported a net loss of $1.6 million for the three months ended June 30, 2007, with total assets of $8.99 million and stockholders' equity of $8.02 million. The filing also includes details about stock transactions and financing activities.

2007-08-15 · 0000950134-07-018327

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

3,192,900 shares

Common

The current 424B3 filing for Novint Technologies, Inc. serves as a prospectus supplement updating the August 13, 2007 prospectus with unaudited financial statements for the quarter ended June 30, 2007. The filing highlights significant operating losses, a net loss of $1.6 million for the six months ended June 30, 2007, and details about equity transactions including stock issuances and warrant exercises. The company remains focused on haptics technology development and expansion into consumer gaming markets.

2007-08-15 · 0000950134-07-018326

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows EFFECT and confirms the priced prospectus.

3,192,900 shares · Gross proceeds $0.00

Common Stock · Exchange OTCBB · Ticker NVNT · 2,777,900 shares underlying common stock purchase warrants · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be used for general corporate purposes, including working capital

The current 424B3 filing by Novint Technologies, Inc. (formerly Dror Ortho-Design, Inc.) outlines a prospectus for the resale of 3,192,900 shares of common stock by selling shareholders. This includes 415,000 shares directly and 2,777,900 shares from warrants. The company will not receive proceeds from the sale but may receive up to $4,034,900 if warrants are exercised, which will be used for general corporate purposes. The filing emphasizes risks related to market adoption of haptics technology and reliance on a limited number of customers.

2007-08-13 · 0000950134-07-017921

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows EFFECT and marks the registration effective.

The filing represents the effectiveness of a registration statement for 20,136,113 shares of common stock, including 10,081,113 shares and 10,055,000 shares underlying warrants, for resale by selling shareholders. The company, Novint Technologies, Inc., develops haptic technology for interactive computing applications and has experienced significant net losses. Proceeds from warrant exercises will be used for general corporate purposes.

2007-08-10 · 9999999995-07-003239

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

20,136,113 shares

Common Stock · Exchange OTCBB · Ticker NVNT · 10,055,000 shares of common stock underlying common stock purchase warrants · Selling stockholders only · Use of proceeds Proceeds from warrant exercises will be used for general corporate purposes, including working capital

Novint Technologies, Inc. is registering 20,136,113 shares of common stock for resale by selling shareholders, including 10,081,113 shares of common stock and 10,055,000 shares underlying warrants. The offering follows a prior SB-2 registration (EFFECT filing) and includes detailed risk factors, financial disclosures, and a plan of distribution. The company, which develops haptic technology for interactive applications, has a history of operating losses and relies on a limited number of customers. Proceeds from warrant exercises, up to $15 million, will be used for general corporate purposes.

2007-06-19 · 0000950134-07-013626

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

First tracked pre-IPO filing for this issuer.

The SEC declared the registration statement for Novint Technologies, Inc. effective on June 18, 2007, allowing the company to proceed with its securities offering. The filing includes unaudited financial statements as of March 31, 2006, showing significant operating losses, negative equity, and liquidity challenges. The previous 424B3 filing included financial updates, distribution plans with Hunter World Markets, and clarifications about securities titles.

2007-06-18 · 9999999995-07-002442

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

9,124,655 shares

Common Stock · 250,000 warrants to purchase common stock with an exercise price of $2.00 · Use of proceeds for working capital and general corporate purposes · Underwriters Hunter World Markets, Inc.

The current 424B3 filing for Novint Technologies, Inc. updates financial disclosures with Q1 2006 results, revises the Plan of Distribution to include details about Hunter World Markets' role in reselling shares, and clarifies the classification of securities held by Hunter World Markets. The filing supplements the earlier prospectus dated February 6, 2006, with additional financial and procedural information.

2006-06-01 · 0000950129-06-005955

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

First tracked pre-IPO filing for this issuer.

Price $1.00 · 9,124,655 shares

Common Stock, $0.01 par value · Selling stockholders only · Use of proceeds We will not receive any of the proceeds from the sale of the common stock by the selling security holders

Novint Technologies, Inc. is registering 9,124,655 shares of common stock for resale by selling stockholders, with an initial offering price of $1.00 per share. The company develops haptics technology for computer touch interaction, has not yet sold consumer products, and relies on professional services revenue. It has incurred significant cumulative losses and faces risks related to market adoption, customer concentration, and operational sustainability. The offering is part of its initial public offering, with proceeds not benefiting the company directly.

2006-02-07 · 0000950129-06-001093